The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Mchugh, Dan
    Investor born in March 1992
    Individual (1 offspring)
    Officer
    2022-04-28 ~ now
    OF - Director → CIF 0
  • 2
    Balasubramanian, Shankar, Prof Sir
    University Professor born in September 1966
    Individual (4 offsprings)
    Officer
    2020-01-08 ~ now
    OF - Director → CIF 0
    Prof Sir Shankar Balasubramanian
    Born in September 1966
    Individual (4 offsprings)
    Person with significant control
    2020-01-08 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Yerramilli-rao, Bobby Satyadev, Dr
    Investor born in May 1966
    Individual (6 offsprings)
    Officer
    2024-06-06 ~ now
    OF - Director → CIF 0
  • 4
    Dr Samuel Aparicio
    Born in October 1963
    Individual (1 offspring)
    Person with significant control
    2025-01-25 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
Ceased 4
  • 1
    Dr Bobby Satyadev Yerramilli-rao
    Born in May 1966
    Individual (6 offsprings)
    Person with significant control
    2020-01-08 ~ 2020-01-29
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Aparicio, Samuel, Dr
    Born in October 1963
    Individual (1 offspring)
    Officer
    2022-04-28 ~ 2024-06-06
    OF - Director → CIF 0
    Dr Samuel Aparicio
    Born in October 1963
    Individual (1 offspring)
    Person with significant control
    2022-04-22 ~ 2024-10-18
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Mahmood, Saiyed Ibraheem
    Director born in October 1973
    Individual (1 offspring)
    Officer
    2024-06-06 ~ 2024-12-02
    OF - Director → CIF 0
  • 4
    Suite 2, Ground Floor, Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom
    Active Corporate (13 parents, 476 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2020-01-08 ~ 2025-01-07
    PE - Secretary → CIF 0
parent relation
Company in focus

GENOME THERAPEUTICS LTD

Previous name
INFLEX LIMITED - 2024-06-15
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
47,000 GBP2024-06-30
53,000 GBP2023-06-30
Property, Plant & Equipment
37,397 GBP2024-06-30
48,408 GBP2023-06-30
Fixed Assets
84,397 GBP2024-06-30
101,408 GBP2023-06-30
Debtors
471,242 GBP2024-06-30
268,640 GBP2023-06-30
Cash at bank and in hand
1,473,887 GBP2024-06-30
3,246,655 GBP2023-06-30
Current Assets
1,945,129 GBP2024-06-30
3,515,295 GBP2023-06-30
Net Current Assets/Liabilities
1,622,657 GBP2024-06-30
3,182,205 GBP2023-06-30
Total Assets Less Current Liabilities
1,707,054 GBP2024-06-30
3,283,613 GBP2023-06-30
Net Assets/Liabilities
1,707,054 GBP2024-06-30
3,283,613 GBP2023-06-30
Equity
Called up share capital
114 GBP2024-06-30
106 GBP2023-06-30
Share premium
4,699,365 GBP2024-06-30
4,291,439 GBP2023-06-30
Retained earnings (accumulated losses)
-3,473,502 GBP2024-06-30
-1,007,934 GBP2023-06-30
Average Number of Employees
62023-07-01 ~ 2024-06-30
42022-07-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Other
60,000 GBP2024-06-30
60,000 GBP2023-06-30
Intangible Assets
Other
47,000 GBP2024-06-30
53,000 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
56,552 GBP2024-06-30
55,017 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
19,155 GBP2024-06-30
6,609 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
12,546 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment
Plant and equipment
37,397 GBP2024-06-30
48,408 GBP2023-06-30
Trade Creditors/Trade Payables
Current
225,748 GBP2024-06-30
220,462 GBP2023-06-30
Other Taxation & Social Security Payable
Current
27,504 GBP2024-06-30
11,498 GBP2023-06-30

  • GENOME THERAPEUTICS LTD
    Info
    INFLEX LIMITED - 2024-06-15
    Registered number 12392992
    Regent House, 316 Beulah Hill, London SE19 3HF
    Private Limited Company incorporated on 2020-01-08 (5 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.